Rogier Reijmers

12PUBLICATIONS
99CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 04, 2026
Bifunctional Phagocytic Synapse Enhancers Remodel the Tumor Microenvironment to Overcome Immunosuppression.

|Aug 05, 2025
Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function.

Marta Barisa, Henrike P Muller, Elisa Zappa

|Dec 23, 2023
SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity.

Panagiota Bouti, Colin Blans, Bart J A M Klein

|Jul 03, 2023
Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy.

Lydia Lee, Wen Chean Lim, Daria Galas-Filipowicz

|Dec 08, 2021
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence.

Afroditi Katsarou, Maria Sjöstrand, Jyoti Naik

|Nov 13, 2021
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML.

Dyantha I van der Lee, Georgia Koutsoumpli, Rogier M Reijmers

Pageof 2

Frequent Collaborators

2 joint publications

Mirjam H M Heemskerk

2 joint publications

Jasper J Koning

1 joint publications

Jie Yang

1 joint publications

Ferry Cornelissen